Clinical Outcomes of Weight-Based Norepinephrine Dosing in Underweight and Morbidly Obese Patients: A Propensity-Matched Analysis

Abstract

Background:

Weight-based dosing strategy for norepinephrine in septic shock patients with extremes of body mass index has been lesser studied.

Methods:

This historical study of adult septic shock patients was conducted from January 1, 2010, to December 31, 2015, at all intensive care units (ICUs) in Mayo Clinic, Rochester. Patients with documented body mass index were classified into underweight (body mass index <18.5 kg/m²), normal weight (18.5-24.9 kg/m²), and morbidly obese (≥40 kg/m²) patients. Patients with repeat ICU admissions, ICU stay <1 day, and body mass index 25 to 39.9 kg/m² were excluded. The primary outcome was in-hospital mortality, and secondary outcomes included cumulative norepinephrine exposure acute kidney injury, cardiac arrhythmias, and 1-year mortality. Two-tailed P < .05 was considered statistically significant.

Results:

From 2010 to 2015, 2016 patients met inclusion—145, 1406, and 466 patients, respectively, in underweight, normal weight, and morbidly obese cohorts. Underweight patients used the highest peak dose and absolute exposure was greatest for morbidly obese patients. In-hospital mortality decreased with increasing log₁₀ body mass index: 41.4% (underweight), 28.4% (normal weight), and 24.7% (morbidly obese), respectively (P < .001); however, this relationship was not noted at 1 year. Unadjusted log₁₀ norepinephrine cumulative exposure (mg) was associated with higher in-hospital mortality, acute kidney injury, cardiac arrhythmias, and 1-year mortality. After adjustment for demographics, body mass index, comorbidity, and illness severity, log₁₀ norepinephrine exposure was an independent predictor of in-hospital mortality (odds ratio 2.4 [95% confidence interval, 2.0-2.8]; P < .001) and 1-year mortality (odds ratio 1.7 [95% confidence interval, 1.5-2.0]; P < .001). In a propensity-matched analysis of 1140 patients, log₁₀ norepinephrine was an independent predictor of in-hospital mortality (odds ratio 2.2 [95% confidence interval, 1.8-2.6]; P < .001).

Conclusions:

Morbidly obese patients had lower in-hospital mortality but had higher 1-year mortality compared to normal weight and underweight patients. Cumulative norepinephrine exposure was highest in morbidly obese patients. Total norepinephrine exposure was an independent mortality predictor in septic shock.

Keywords

septic shock norepinephrine obesity underweight mortality

Get full access to this article

View all access options for this article.

References

Angus

Linde-Zwirble

Lidicker

Clermont

Carcillo

Pinsky

. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310.

Antonucci

Fiaccadori

Donadello

Taccone

Franchi

Scolletta

. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. J Crit Care. 2014;29(4):500–511.

Vallabhajosyula

Jentzer

Geske

, et al. New-onset heart failure and mortality in hospital survivors of sepsis-related left ventricular dysfunction. Shock. 2018;49(2):144–149.

Vallabhajosyula

Kumar

Pandompatam

, et al. Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study. Ann Intensive Care. 2017;7(1):94.

Vallabhajosyula

Sakhuja

Geske

, et al. Role of admission troponin-T and serial troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Assoc. 2017;6(9):e005930.

Rhodes

Evans

Alhazzani

, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.

Asfar

Meziani

Hamel

, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583–1593.

Jentzer

Vallabhajosyula

Khanna

Chawla

Busse

Kashani

. Management of refractory vasodilatory shock [published online ahead of print January 9, 2018]. Chest. 2018:1–11.

Radosevich

Patanwala

Erstad

. Norepinephrine dosing in obese and nonobese patients with septic shock. Am J Crit Care. 2016;25(1):27–32.

10.

Vadiei

Daley

Murthy

Shuman

. Impact of norepinephrine weight-based dosing compared with non-weight-based dosing in achieving time to goal mean arterial pressure in obese patients with septic shock. Ann Pharmacother. 2017;51(3):194–202.

11.

Trivedi

Bavishi

Jean

. Impact of obesity on sepsis mortality: a systematic review. J Crit Care. 2015;30(3):518–524.

12.

Medico

Walsh

. Pharmacotherapy in the critically ill obese patient. Crit Care Clin. 2010;26(4):679–688.

13.

Adams

Tucker

Allen

, et al. Disparities in hemodynamic resuscitation of the obese critically ill septic shock patient. J Crit Care. 2017;37:219–223.

14.

Afessa

Keegan

Hubmayr

, et al. Evaluating the performance of an institution using an intensive care unit benchmark. Mayo Clin Proc. 2005;80(2):174–180.

15.

Herasevich

Pickering

Dong

Peters

Gajic

. Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc. 2010;85(3):247–254.

16.

Singer

Deutschman

Seymour

, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.

17.

Singh

Ahmed

, et al. Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records. Mayo Clin Proc. 2012;87(9):817–824.

18.

Ahmed

Vairavan

Akhoundi

, et al. Development and validation of electronic surveillance tool for acute kidney injury: a retrospective analysis. J Crit Care. 2015;30(5):988–993.

19.

Rocca

Yawn

St Sauver

Grossardt

Melton

III . History of the Rochester epidemiology project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87(12):1202–1213.

20.

O’Brien

Jr Phillips

Ali

Lucarelli

Marsh

Lemeshow

. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med. 2006;34(3):738–744.

21.

Finkielman

Gajic

Afessa

. Underweight is independently associated with mortality in post-operative and non-operative patients admitted to the intensive care unit: a retrospective study. BMC Emerg Med. 2004;4(1):3.

22.

Arabi

Dara

Tamim

, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17(2):R72.

23.

Vachharajani

Vital

. Obesity and sepsis. J Intensive Care Med. 2006;21(5):287–295.

24.

Wacharasint

Boyd

Russell

Walley

. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013;17(3):R122.

25.

Martin

Medam

Antonini

, et al. Norepinephrine: not too much, too long. Shock. 2015;44(4):305–309.

26.

Wilkman

Kaukonen

Pettila

Kuitunen

Varpula

. Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiol Scand. 2013;57(4):431–442.

27.

Brown

Lanspa

Jones

, et al. Survival after shock requiring high-dose vasopressor therapy. Chest. 2013;143(3):664–671.

28.

Anantasit

Boyd

Walley

Russell

. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock. Crit Care Med. 2014;42(8):1812–1820.

29.

De Backer

Biston

Devriendt

, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–789.

30.

Beale

Hollenberg

Vincent

Parrillo

. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32(suppl 11): S455–S465.

31.

Vallabhajosyula

Sakhuja

Geske

, et al. Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: an eight-year cohort study. PLoS One. 2018;13(1):e0190965.

32.

Kotecha

Vallabhajosyula

Coville

Kashani

. Cardiorenal syndrome in sepsis: a narrative review. J Crit Care. 2018;43:122–127.